Horizon Diagnostics, EMQN Ink Deal for Cell Line Reference Standards | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Horizon Diagnostics will provide genetically defined human cell line reference standards for distribution to molecular diagnostic laboratories worldwide under a deal with the European Molecular Genetics Quality Network (EMQN) announced today.

The cell line references will be distributed as part of EMQN's annual external quality assessment schemes to ensure sensitivity and reproducibility of diagnostic assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.